Provider review
Belle Health review
Promises the price won't rise with your dose — then prints three tirzepatide rates.
The flat-rate promise and the tirzepatide price card contradict each other on the same site. One says the price doesn't move with the dose; the other conditions its cheapest tirzepatide rate on you being at the starter dose. And three tirzepatide rates appear as current, not one.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Belle Health
$119/mo semaglutide · tirzepatide $175–$219, unresolved
- Vs median
- $50/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Compounded by BPI Labs · Hallandale Health (Hallandale Beach, FL) · Boudreaux's Compounding Pharmacy · VialsRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take a quarter dose of semaglutide here and you pay the full-dose rate — Belle's own line is "Flat-rate pricing — Your price doesn't go up when your dose does". On tirzepatide the promise breaks: the cheapest rate on the product page is labeled starter-dose only, and a price conditioned on staying at the starter dose is not a flat price. Give Belle credit where it earns it. It names all four compounding pharmacies, one with a city and state. It sells a named tirzepatide microdose with its own page and FAQ. And it says outright that it is not the pharmacy. Two things will cost you. Three different tirzepatide rates appear as current across three surfaces, with nothing reconciling them, so you cannot know what recurs. And the microdose is filed under longevity, with the copy managing your weight-loss expectations down.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to know which pharmacies fill your prescription. All four are named.
- You are buying semaglutide and want one rate that holds when your dose moves.
- You want a low dose sold as its own product, and you are treating it as metabolic support rather than weight loss.
- You want the brand-name figures you are being compared against printed on the same page.
Look elsewhere if
- You are taking less to spend less on semaglutide. That is the structure charging full price for a quarter of the drug.
- You are budgeting tirzepatide. Three standing rates appear across the site and nothing says which one recurs.
- You read the cheapest tirzepatide figure as your ongoing price. It is conditioned on staying at the starter dose.
- You want a microdose framed as weight loss. Belle's own copy says it is not.
What it actually costs
Price as published
Compounded semaglutide $119/month standing · compounded tirzepatide is published three ways with nothing reconciling them: the comparison table says "$199/mo", the product page says "from $175 / month" and "Reg $219" · the $175 is restricted — "New to GLP-1s (starter-dose only). Reg $219." · a named Compounded Tirzepatide Microdose from $99/month, filed under Longevity with its own page · no prepay rungs published · billing is "/ month" with "Cancel anytime — No memberships, no contracts, no lock-ins" and no week count · brand comparison priced on the same page: Zepbound $1,999/mo, Wegovy $1,400/mo
- Vs median
- $50/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. The row records a flat-rate promise stated in the provider's own words on its treatments page, covering both molecules. It also records that the promise is contradicted on the same site by a tirzepatide rate restricted to starter doses, and that three tirzepatide figures appear as current with nothing reconciling them — so the tier describes the stated dose-to-price relationship, not a settled one. A separately named tirzepatide microdose exists, but it is filed under longevity, its copy manages weight-loss expectations down, and the flat-rate statement is not repeated on it.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- Names all four compounding pharmacies, with a city and state for one — most providers in this category name none
- States the dose basis outright — "Flat-rate pricing — Your price doesn't go up when your dose does" — instead of leaving a reader to infer it
- Publishes a full cross-treatment comparison table with frequency and FDA status per row, including the $1,400–$2,000 brand-name figures it is competing against
- Sells a named microdose SKU at $99/month and gives it its own page and FAQ, including "Will I lose weight on a microdose?"
- States plainly that it is not the pharmacy: "Belle is not the compounding pharmacy or manufacturer"
- Every price is public, with no intake gate in front of it
Pharmacy, labs and oversight
Belle Health dispenses through a BPI Labs · Hallandale Health (Hallandale Beach, FL) · Boudreaux's Compounding Pharmacy · VialsRx facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
4 of 4 published openly
What Belle Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Belle Health sells compounded semaglutide and compounded tirzepatide as subcutaneous injections, with prices published openly on its treatments pages and a full cross-treatment comparison table beside them. A separate longevity line carries a named Compounded Tirzepatide Microdose with its own page and FAQ. It names four compounding pharmacies — BPI Labs, Hallandale Health of Hallandale Beach FL, Boudreaux's Compounding Pharmacy and VialsRx — and states plainly that it is not the pharmacy or manufacturer. State eligibility is confirmed during a free screening rather than against a published list.
The honest cons
ONE PRICE AT EVERY DOSE IS THE STRUCTURE THIS SITE EXISTS TO FLAG. "Your price doesn't go up when your dose does" cuts both ways — a patient deliberately holding a quarter dose of semaglutide pays the identical $119 as one at the top of the range
- THE FLAT PROMISE AND THE TIRZEPATIDE PRICE CONTRADICT EACH OTHER ON THE SAME SITE. /treatments says the price does not rise with the dose; the tirzepatide product page sells $175 as "New to GLP-1s (starter-dose only). Reg $219." A price conditioned on being at the starter dose is by definition not flat
- THREE CURRENT TIRZEPATIDE RATES, NO RECONCILING SENTENCE — $175, $199 and $219 all appear as current across three surfaces
- The microdose SKU is filed under Longevity rather than Weight Loss, and the copy manages expectations down: "Rather than driving significant weight loss, it's prescribed to support metabolic health as part of a longevity-focused routine"
- Whether the $99 microdose is itself flat across doses is not stated — the flat-rate promise sits on /treatments and is not repeated on the microdose page
- No week count is published against "/ month", so an annual cost cannot be computed
- States served are not published — only "Belle currently serves patients in most US states"
- Claims "50,000+ patients. Real results." with a single named testimonial as support
- A separate promotional domain, glpwinner.com, is linked from the home page
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Belle Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#84 of 373
Ordered with the companies that pay us first, and Belle Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.